Variation of initial serum bilirubin rise in newborn infants with type of illness

Area of Science:

• Neonatal medicine
• Biochemistry
• Pediatrics

Background:

• Neonatal hyperbilirubinemia is common and typically viewed as a pathological condition.
• Bilirubin is often considered a toxic metabolic byproduct.
• The high incidence in newborns suggests a potential beneficial role for excess neonatal bilirubin.

Purpose of the Study:

• To investigate the hypothesis that bilirubin functions as a free-radical scavenger in newborn infants.
• To determine if illnesses associated with increased free-radical production affect the rate of serum bilirubin rise.

Main Methods:

• Measured serum bilirubin rise in the first few days of life in 44 infants with illnesses linked to free-radical production and 58 control infants.
• Infants were selected from 2700 births, excluding factors affecting bilirubin metabolism like enteral feeding.
• Control infants were ill but without disorders related to free-radical production.

Main Results:

• The mean serum bilirubin rise was significantly lower in the illness group (36.1 mumol.l-1.day-1) compared to the control group (66.7 mumol.l-1.day-1) (p < 0.0001).
• Subgroup analyses showed significantly lower bilirubin rises in infants with circulatory failure, neonatal depression/asphyxia, aspiration syndromes, and sepsis.
• No significant difference in bilirubin rise was observed between infants with respiratory distress and their matched controls.

Conclusions:

• Findings support the hypothesis that bilirubin is consumed in vivo as an antioxidant.
• This antioxidant consumption may occur alongside standard bilirubin metabolism pathways.
• Neonatal hyperbilirubinemia might represent an adaptive mechanism against oxidative stress.